Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2 Breast 2 Thoracic 1 Plasma cell 1

Conditions

Multiple Myeloma 1

Interventions

Dexamethasone 136 Lenalidomide 79 daratumumab 77 Bortezomib 66 pomalidomide 48 Cyclophosphamide 48 carfilzomib 43 Calcium Dobesilate 42 Specimen Handling 35 Biopsy 32 Magnetic Resonance Spectroscopy 29 belantamab mafodotin 26 fludarabine 23 isatuximab 22 iberdomide 19 dexamethasone acetate 19 dexamethasone 21-phosphate 19 auricularum 19 Melphalan 18 talquetamab 17 fludarabine phosphate 14 elotuzumab 12 selinexor 11 X-Rays 10 tocilizumab 9 Nivolumab 8 trametinib 7 Whole-Body Irradiation 7 Sirolimus 7 Crizotinib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Diet, Ketogenic × Plasma cell × 90 days × Clear all

NCT07564219 2026-05-04

BEAM-MM

Universitätsklinikum Hamburg-Eppendorf

Phase NA Recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡